The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Luitpold Pharmaceuticals (I)
Stock and Other Ownership Interests - Alnylam; Ions Pharmaceuticals
Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal cancer hepatic metastases (CRLM).
 
Nancy E. Kemeny
Research Funding - Amgen
 
Haley Hauser
No Relationships to Disclose
 
Marinela Capanu
No Relationships to Disclose
 
T. Peter Kingham
Consulting or Advisory Role - Physicans' Education Resource
 
William R. Jarnagin
No Relationships to Disclose
 
Ronald P. DeMatteo
No Relationships to Disclose
 
Andrea Cercek
Consulting or Advisory Role - Amgen; Bayer
Research Funding - Abbvie; Amgen; Bayer
 
Vinod P. Balachandran
Research Funding - Bristol-Myers Squibb
 
Jeffery A. Drebin
No Relationships to Disclose
 
Michael Ian D'Angelica
No Relationships to Disclose